Citadel Advisors’s UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian MLPL Stock Holding History
Bought
Maintained
Sold
Other funds holding MLPL
PSI
WRM
Citadel Advisors's MLPL Position: Q4 2015 in Review
Citadel Advisors sold out of UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian (MLPL) in Q4 2015, closing a stake of 9,470 shares — an estimated $232K sold.
Citadel Advisors first reported a position in MLPL in Q3 2015 and held it in 1 quarter. The position peaked at $232K in Q3 2015. 18 funds tracked by Wall St. Rank hold MLPL as of Q4 2015.
- Citadel Advisors reported no remaining UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian position as of Q4 2015 after selling out during the quarter.
- Citadel Advisors sold 9,470 UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian shares in Q4 2015, an estimated $232K.
- Citadel Advisors first reported a position in UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian in Q3 2015 and held it in 1 quarter.
- Citadel Advisors's UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian position peaked at $232K in Q3 2015.
- 18 funds tracked by Wall St. Rank held UBS 2X Monthly Leveraged Long Exchange Traded Access Securities E-TRACS Alerian as of Q4 2015.
Based on Citadel Advisors's 13F filing for Q4 2015, filed 12 Feb 2016.